PUBLIC COMPANY
save$KLRAKailera Therapeutics, Inc.
$KLRA17.46-4.69%Waltham, MA, USupdated 8h ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
earnings (1)
Active trials
Insider activity
source: SEC Form 4open-market buys + sells
routine RSU / option mechanics (6)
- Apr 20, 26cJiangsu Hengrui Pharmaceuticals Co., Ltd. · 4,968,789 sh
- Apr 20, 26cJiangsu Hengrui Pharmaceuticals Co., Ltd. · 2,034,133 sh
- Apr 20, 26cRTW INVESTMENTS, LP · 8,250,000 sh
- Apr 20, 26cBAIN CAPITAL INVESTORS LLC · 10% owner17,857,143 sh
- Apr 20, 26cBain Capital Life Sciences Investors, LLC · 10% owner16,875,000 sh
- Apr 20, 26cKoppel Adam · 10% owner16,875,000 sh
🐶 Hiring Signal
Where Kailera Therapeutics, Inc. is staffing up — a leading indicator of pipeline and commercial priorities.
therapeutic areaMetabolic 17Oncology 1
News
- Scribe reels in nearly $129M in rare early-stage IPO for a gene editing biotechJennifer Doudna–founded Scribe Therapeutics intends to use the proceeds from the public offering—the first for a gene editing outfit in over two years—to support development of its epigenetic silen…biospace · 27d ago
- Biotech startup funding gap widens despite rebound in VC investmentThough funding totals represented the highest first-half sum since the start of 2022, industry watchers are concerned that small startups are being left behind.biopharma_dive · 1mo ago
- At BIO, tension over China biotech deal regulation loomsBiotech investors, executives and analysts worry that blanket bans on deals with Chinese companies could curb domestic entrepreneurs’ ambitions in the sector.biopharma_dive · 1mo ago
- Bristol Myers, Hengrui join forces in drugmaking alliance worth up to $15.2 billionThe wide-ranging pact involves as many as 13 drugs and marks the latest example of the growing relationship between Chinese pharmaceutical firms and their U.S. and Europe-based counterparts.biopharma_dive · 3mo ago
Data sources
last refreshed 19m ago
Found something off?
comments(0)
5-min edit window · permanent after that